- $547.07m
- $526.72m
- CA$909.01m
- 51
- 62
- 89
- 75
R2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 40-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 63.6 | 60.9 | 56.1 | 712 | 909 |
Cost of Revenue | |||||
Gross Profit | 16.8 | 9.18 | 5.52 | 154 | 220 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 185 | 250 | 221 | 1,078 | 1,090 |
Operating Profit | -121 | -189 | -165 | -366 | -181 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -146 | -206 | -235 | -380 | -172 |
Provision for Income Taxes | |||||
Net Income After Taxes | -143 | -206 | -227 | -372 | -172 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -271 | -233 | -227 | -335 | -173 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -271 | -233 | -227 | -335 | -173 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -11 | -0.811 | -0.912 | -0.878 | -0.196 |